JP2008519788A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519788A5
JP2008519788A5 JP2007540573A JP2007540573A JP2008519788A5 JP 2008519788 A5 JP2008519788 A5 JP 2008519788A5 JP 2007540573 A JP2007540573 A JP 2007540573A JP 2007540573 A JP2007540573 A JP 2007540573A JP 2008519788 A5 JP2008519788 A5 JP 2008519788A5
Authority
JP
Japan
Prior art keywords
dihydro
oxo
carboxy
dimethylamino
erythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007540573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519788A (ja
Filing date
Publication date
Priority claimed from GB0424959A external-priority patent/GB0424959D0/en
Application filed filed Critical
Publication of JP2008519788A publication Critical patent/JP2008519788A/ja
Publication of JP2008519788A5 publication Critical patent/JP2008519788A5/ja
Withdrawn legal-status Critical Current

Links

JP2007540573A 2004-11-11 2005-11-09 マクロロン−アミノ置換キノロン Withdrawn JP2008519788A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424959A GB0424959D0 (en) 2004-11-11 2004-11-11 Novel compounds
PCT/EP2005/012038 WO2006050942A1 (en) 2004-11-11 2005-11-09 Macrolones - amino substituted quinolones

Publications (2)

Publication Number Publication Date
JP2008519788A JP2008519788A (ja) 2008-06-12
JP2008519788A5 true JP2008519788A5 (https=) 2008-12-25

Family

ID=33523587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540573A Withdrawn JP2008519788A (ja) 2004-11-11 2005-11-09 マクロロン−アミノ置換キノロン

Country Status (19)

Country Link
US (2) US7718621B2 (https=)
EP (1) EP1824870A1 (https=)
JP (1) JP2008519788A (https=)
KR (1) KR20070085919A (https=)
CN (1) CN101098881A (https=)
AR (1) AR053311A1 (https=)
AU (1) AU2005303961A1 (https=)
BR (1) BRPI0517792A (https=)
CA (1) CA2587413A1 (https=)
GB (1) GB0424959D0 (https=)
IL (1) IL182978A0 (https=)
MA (1) MA29213B1 (https=)
MX (1) MX2007005776A (https=)
NO (1) NO20072939L (https=)
PE (1) PE20061137A1 (https=)
RU (1) RU2007121581A (https=)
TW (1) TW200630378A (https=)
WO (1) WO2006050942A1 (https=)
ZA (1) ZA200703603B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
WO2006120545A1 (en) * 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 4' amino linked macrolides useful for the treatment of microbial infections
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
EP2201010B1 (en) 2007-09-14 2013-11-06 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
CN105732745A (zh) 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
AU2009308182B2 (en) 2008-10-24 2016-05-19 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
CN105198944B (zh) 2010-05-20 2018-06-01 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
MX2014011537A (es) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Formulaciones parenterales para la administracion de antibioticos macrolidos.
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов
CN106589023A (zh) * 2016-11-22 2017-04-26 宜昌东阳光药业股份有限公司 一种罗红霉素杂质及其合成方法
EP3601282B1 (en) 2017-03-30 2021-07-21 F. Hoffmann-La Roche AG Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Similar Documents

Publication Publication Date Title
JP2008519788A5 (https=)
CA2548654C (en) Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
ES2241513T3 (es) Compuestos de piridazino-quinolina.
AU2011334602B2 (en) Compounds for treating respiratory syncytial virus infections
JP2021523225A5 (https=)
ES2732902T3 (es) Bencimidazol-2-aminas como inhibidores de MIDH1
JP2007516983A5 (https=)
CN103796654B (zh) 氘富集化4-羟基-5-甲氧基-n,1-二甲基-2-氧代-n-[(4-三氟-甲基)苯基]-1,2-二氢喹啉-3-甲酰胺
JP2016520618A5 (https=)
JP2007511613A5 (https=)
JP2020502049A5 (https=)
JP2009530424A5 (https=)
JP2010509375A5 (https=)
JP2005504055A5 (https=)
RU2007121581A (ru) Макролоны-аминозамещенные хинолоны
BRPI0714840A2 (pt) composto, processo para a preparaÇço e uso do mesmo, composiÇço farmacÊutica, processo para a preparaÇço da mesma, e, produto
JP2008526999A5 (https=)
JP5925680B2 (ja) キナーゼインヒビター、そのプロドラッグ型および治療におけるそれらの使用
JP2010501478A5 (https=)
CN108025191A (zh) 治疗癌症的方法
JP2007516205A5 (https=)
JP2014511898A5 (https=)
JP2007501779A5 (https=)
ES2687826T3 (es) Arilhidrazidas que contienen una fracción de 2-piridona como agentes antibacterianos selectivos
JP2007538031A5 (https=)